Hangzhou Biotest BiotechLtd Balance Sheet Health
Financial Health criteria checks 6/6
Hangzhou Biotest BiotechLtd has a total shareholder equity of CN¥2.4B and total debt of CN¥299.0K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are CN¥2.5B and CN¥151.0M respectively. Hangzhou Biotest BiotechLtd's EBIT is CN¥45.4M making its interest coverage ratio -0.7. It has cash and short-term investments of CN¥1.6B.
Key information
0.01%
Debt to equity ratio
CN¥299.03k
Debt
| Interest coverage ratio | -0.7x |
| Cash | CN¥1.61b |
| Equity | CN¥2.38b |
| Total liabilities | CN¥150.96m |
| Total assets | CN¥2.53b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688767's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥140.3M).
Long Term Liabilities: 688767's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥10.7M).
Debt to Equity History and Analysis
Debt Level: 688767 has more cash than its total debt.
Reducing Debt: 688767's debt to equity ratio has reduced from 24.5% to 0.01% over the past 5 years.
Debt Coverage: 688767's debt is well covered by operating cash flow (68190.6%).
Interest Coverage: 688767 earns more interest than it pays, so coverage of interest payments is not a concern.